Liaison free PSA--an automated chemiluminescent immunoassay for the determination of free prostate specific antigen (fPSA)
König, B.; Ivankovic, B.; Schleff, R.; Mack, M.
Anticancer Research 19(4A): 2763-2765
1999
ISSN/ISBN: 0250-7005 PMID: 10470237 Document Number: 502127
The LIAISON(R) fPSA offers a rapid, reliable and precise method for the fully automated determination of free PSA.
Document emailed within 1 workday
Related Documents
Oed, M.; Amtmann, R.; Löwer, Y.; Schlett, R.; Mack, M. 1999: LIAISON hCG--an automated chemiluminescent immunoassay for the determination of human chorionic gonadotropin (hCG) Anticancer Research 19(4A): 2735-2737König, B.; Oed, M.; Kunz, A.; Schlett, R.; Mack, M. 1999: LIAISON Ferritin--an automated chemiluminescent immunoassay for the determination of Ferritin Anticancer Research 19(4a): 2739-2741
Nixon, R.G.; Lilly, J.D.; Liedtke, R.J.; Batjer, J.D. 1997: Variation of free and total prostate-specific antigen levels: the effect on the percent free/total prostate-specific antigen Archives of Pathology and Laboratory Medicine 121(4): 385-391
Mitrunen, K.; Pettersson, K.; Piironen, T.; Björk, T.; Lilja, H.; Lövgren, T. 1995: Dual-label one-step immunoassay for simultaneous measurement of free and total prostate-specific antigen concentrations and ratios in serum Clinical Chemistry 41(8 Pt 1): 1115-1120
Molina, R.; Bonfrer, J.; Banfi, G.; Marie-José Bugugnani; Cornu, F.; Hannemann, K.-Pohl; Hubl, W.; Merz, O.; Bach, M. and Michael Mack 2000: External Evaluation of LIAISON® Tumour Marker Assays on the Fully Automated Chemiluminescent LIAISOIN® Immunoassay Analyser Clinical Laboratory 46(3-4): 169-179
Lieberman, S. 1999: Can percent free prostate-specific antigen reduce the need for prostate biopsy? Effective Clinical Practice: Ecp 2(6): 266-271
Maeda, H.; Arai, Y.; Ishitoya, S.; Okubo, K.; Aoki, Y.; Okada, T.; Maekawa, S. 1998: Free-to-total prostate specific antigen ratio in clinical staging of prostate cancer Hinyokika Kiyo. Acta Urologica Japonica 44(5): 307-311
De la Taille, A.; Houlgatte, A.; Houdelette, P.; Berlizot, P.; Ramirez, J.; Ricordel, I. 1997: Value of free/total prostate specific antigen in the early diagnosis of prostate cancer (study of 105 patients) Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 7(2): 240-245
Wechsel, H.W.; Gleichmann, R.; Blasseneck, J. 2000: The behavior of prostate specific antigen (PSA) and free-PSA (f-PSA) under antihormonal therapy Anticancer Research 20(6d): 4993-4994
Tommasi, A.; Pazzagli, M.; Damiani, M.; Salerno, R.; Messeri, G.; Magini, A.; Serio, M. 1984: On-line computer analysis of chemiluminescent reactions, with application to a luminescent immunoassay for free cortisol in urine Clinical Chemistry 30(10): 1597-1602
Wu, C.T.; Chuang, C.K.; Chou, C.C.; Chu, S.H.; Chen, H.W.; Chen, C.S.; Chiang, Y.J.; Liao, S.K. 2000: The role of free to total prostate-specific antigen ratio for prostate cancer in screening patients with total serum levels between 4 and 20 ng/ml Chang Gung Medical Journal 23(3): 142-148
Jung, K.; Stephan, C.; Lein, M.; Henke, W.; Schnorr, D.; Brux, B.; Schürenkämper, P.; Loening, S.A. 1996: Analytical performance and clinical validity of two free prostate-specific antigen assays compared Clinical Chemistry 42(7): 1026-1033
Scattoni, V.; Raber, M.; Montorsi, F.; Da Pozzo, L.; Brausi, M.; Calori, G.; Freschi, M.; Rigatti, P. 1999: Percent of free serum prostate-specific antigen and histological findings in patients undergoing open prostatectomy for benign prostatic hyperplasia European Urology 36(6): 621-630
Piketty, M.L.; Bounaud, M.P.; Bounaud, J.Y.; Lebtahi, R.; Valat, C.; Askienazy, S.; Begon, F.; Besnard, J.C. 1992: Multicentre evaluation of a two-step automated enzyme immunoassay of free thyroxine European Journal of Clinical Chemistry and Clinical Biochemistry 30(8): 485-492
Chalkley, S.R.; Renshaw, A. 1980: Microfiltration as a means of separating free antigen from antigen-antibody complexes in immunoassay Methods in Enzymology 70(A): 305-314
España, F.; Sánchez-Cuenca, J.; Estellés, A.; Gilabert, J.; Griffin, J.H.; Heeb, M.J. 1996: Quantitative immunoassay for complexes of prostate-specific antigen with alpha2-macroglobulin Clinical Chemistry 42(4): 545-550
Fornara, P.; Sturm, W.; Fabricius, P.G.; Schmiedt, E. 1987: Clinical relevance of radioimmunologic determination of prostate specific antigen in prostate cancer Der Urologe. Ausg. a 26(3): 158-161
Mannini, D.; Aiello, E.; Maver, P.; Corrado, G.; Vecchi, F.; Bellanova, B. 1987: Simultaneous determination of prostatic acid phosphatase and prostate-specific antigen in carcinoma of the prostate. 2 years' experience Minerva Urologica e Nefrologica 39(4): 335-341
La Brecque, J.J. 1978: The determination of free erythrocyte porphyrins (FEP) by a semi-automated fluorometric technique Acta Cientifica Venezolana 29(6): 479-481
Yoshioka, N.; Deguchi, M.; Kagita, M.; Kita, M.; Watanabe, M.; Asari, S.; Iwatani, Y. 2007: Evaluation of a chemiluminescent microparticle immunoassay for determination of Treponema pallidum antibodies Clinical Laboratory 53(9-12): 597-603